First long-acting injectable HIV treatment approved In England and Wales

The first HIV long-acting injectable treatment will be available to people living with HIV in England and Wales.

The National Institute for Health and Care Excellence (NICE) has approved the first long-acting injectable treatment – for the first time, people living with HIV will now have an alternative to daily tablets. It’s estimated that around 13,000 people will now be eligible for the new treatment.

We firmly believe that those who are most in need of the new treatment, such as those who face the most stigma, should be prioritised.

The decision means that people living with HIV in England and Wales who are undetectable will be able to opt for a long-acting injectable treatment which is administered every two months by a healthcare professional instead of daily oral treatment. Being ‘undetectable’ means the virus is at such low levels it is undetectable in the blood as a result of medication.

This approval of this additional treatment option bring the two nations in line with Scotland who approved the treatment for use on NHS Scotland last month.

Debbie Laycock, Head Of Policy at Terrence Higgins Trust, said: ‘It’s incredible news for people living with HIV in England and Wales that they will be able to access the first long-acting injectable treatment on the NHS as an additional treatment option.

‘We have incredibly effective treatment which means HIV is now a manageable virus, however, it is lifelong so it is important that taking treatment is as easy as possible. HIV unfortunately remains a stigmatised condition.

‘Although we’re working hard to tackle the stigma surrounding HIV, this new injectable treatment option could help people in house-shares for example who do not wish to share their HIV status and will no longer have to worry about hiding their medication. Pill fatigue is also an issue for some people living with HIV who struggle with the idea of taking antiretroviral drugs every day.

‘Long-acting injectable treatment is also a better option for those who have difficulty swallowing medication. Therefore, the institute’s approval provides a welcome additional treatment option for people living with HIV across England and Wales.

‘This is a great step forward as we work towards ending new cases of HIV by 2030. The institute’s decision brings great potential for HIV prevention including long-lasting PrEP (pre-exposure prophylaxis) in the future.’

Speak to someone

We’re open:

10am to 6pm, Monday to Friday
Our phone number is 0808 802 1221.

This is free to call from all UK landlines and most major mobile networks. It won’t appear on your telephone bill.

Live chat

We’re trialling a new live chat service to offer you support without the need to make a phone call.

The chat is open Monday to Friday at the following times:

  • 11am to 1pm
  • 3pm to 5pm

Live chat is anonymous and confidential. We’re offering it alongside our phone helpline, initially at the times given above.

At the end of your chat session, you’ll be directed to an online survey about your experience. Please take a few minutes to fill this in as it helps us to understand how live chat is working. We’ll use this feedback to develop the service further.